News Diagnamed Holdings Corp.

Equities

DMED

CA25245D1033

Market Closed - Canadian Securities Exchange Other stock markets 01:29:00 11/05/2024 am IST			5-day change	1st Jan Change
0.035 ^CAD	0.00%		-12.50%	+16.67%

25/04	Diagnamed?s Brain Age® Brain Health Ai Platform Accomplishes Clinical Validation Milestone with Peer-Reviewed Paper	CI
23/04	DiagnaMed Holdings Corp. Announces Canadian Launch of BRAIN AGE® Brain Health AI	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

DiagnaMed’s BRAIN AGE® Brain Health AI Platform Accomplishes Clinical Validation Milestone with Peer-Reviewed Paper	25/04	GL
DiagnaMed’s BRAIN AGE® Brain Health AI Platform Accomplishes Clinical Validation Milestone with Peer-Reviewed Paper	25/04	AQ
Diagnamed?s Brain Age® Brain Health Ai Platform Accomplishes Clinical Validation Milestone with Peer-Reviewed Paper	25/04	CI
DiagnaMed Announces Canadian Launch of BRAIN AGE® Brain Health AI	23/04	GL
DiagnaMed Holdings Corp. Announces Canadian Launch of BRAIN AGE® Brain Health AI	23/04	CI
DiagnaMed Adds New Launch Site of CERVAI™ Brain Health AI	03/04	GL
DiagnaMed Adds New Launch Site of CERVAI™ Brain Health AI	03/04	AQ
Diagnamed Holdings Corp. Adds New Launch Site of CERVAI Brain Health AI	03/04	CI
DiagnaMed Announces BRAIN AGE Trademark Registration Approved by CIPO	20/03	MT
DiagnaMed Holdings Corp. Announces Brain AGE Trademark Registration Approved by Canadian Intellectual Property Office	20/03	CI
DiagnaMed Announces BRAIN AGE® Trademark Registration Approved by CIPO	20/03	GL
DiagnaMed Strengthening Intellectual Property Support for CERVAI™ Brain Health AI Solution	14/03	GL
DiagnaMed Strengthening Intellectual Property Support for CERVAI™ Brain Health AI Solution	14/03	AQ
DiagnaMed Accelerates Commercialization Initiatives of CERVAI™ Brain Health AI Solution	11/03	GL
DiagnaMed Accelerates Commercialization Initiatives of CERVAI™ Brain Health AI Solution	11/03	AQ
DiagnaMed Holdings Corp. Accelerates Commercialization Initiatives of CERVAI Brain Health AI Solution	11/03	CI
Diagnamed Holdings Corp. Reports Earnings Results for the First Quarter Ended December 31, 2023	01/03	CI
DiagnaMed Announces Test Launch of CERVAI Brain Health in University Brain Health Center	28/02	CI
DiagnaMed Announces Test Launch of CERVAI™ Brain Health in University Brain Health Center	28/02	GL
Diagnamed Holdings Corp. Reports Earnings Results for the Full Year Ended September 30, 2023	30/01	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Diagnamed Holdings Corp.

Equities

DMED

CA25245D1033

Summary

Filters